Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of Radioimmunotherapy-Reference-Cited by-同舟云学术

Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of Radioimmunotherapy

Published:2000-02 Issue:1 Volume:15 Page:71-79
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

DeNardo Sally J.,Burke Patricia A.,Leigh Bryan R.,O'Donnell Robert T.,Miers Laird A.,Kroger Linda A.,Goodman Simon L.,Matzku Siegfried,Jonczyk Alfred,Lamborn Kathleen R.,DeNardo Gerald L.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2000.15.71

Reference26 articles.

1. Integrins: Structure, Function, and Biological Properties

2. Arg-Gly-Asp: A versatile cell recognition signal

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive pan-cancer analysis of KLRB1-CLEC2D pair and identification of small molecule inhibitors to disrupt their interaction;International Immunopharmacology;2024-10

2. Targeted Radionuclide Therapy;Clinical Radiation Oncology;2016

3. Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model;Theoretical Biology and Medical Modelling;2014-04-12

4. Multivalency of Non-Peptide Integrin αVβ3 Antagonist Slows Tumor Growth;Molecular Pharmaceutics;2013-09-05

5. Targeted Radionuclide Therapy—Expanded Content;Clinical Radiation Oncology;2012